Literature DB >> 19485707

Insulin and the brain.

Zvi Laron1.   

Abstract

Circulating insulin crosses the blood-brain barrier (BBB) into the central nervous system (CNS). There are many insulin receptors in various areas of the brain; they are expressed by both astrocytes and neurons. The two main insulin actions in the brain are (a) control of food intake and (b) effect on cognitive functions. In obesity there is a relative insulin deficiency in the CNS despite increased circulating levels. Insulin plays an important role in cognitive functions as demonstrated by the intranasal administration of insulin bypassing the liver. Brain insulin decreases with aging and may be related to the decrease in cognitive functions, as has also been reported in Alzheimer's disease. Certain brain tumours over-express insulin receptors. Whether the larger insulin analogues pass the BBB is as yet not known.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19485707     DOI: 10.1080/13813450902949012

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  33 in total

1.  The effect of intra-cerebroventricular injection of insulin on nociception of formalin test in non-diabetic and short-term diabetic rat models.

Authors:  Sh Balali Dehkordi; J Sajedianfard; A A Owji
Journal:  Iran J Vet Res       Date:  2017       Impact factor: 1.376

2.  Insulin Attenuates Beta-Amyloid-Associated Insulin/Akt/EAAT Signaling Perturbations in Human Astrocytes.

Authors:  Xiaojuan Han; Liling Yang; Heng Du; Qinjian Sun; Xiang Wang; Lin Cong; Xiaohui Liu; Ling Yin; Shan Li; Yifeng Du
Journal:  Cell Mol Neurobiol       Date:  2015-09-10       Impact factor: 5.046

3.  Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficits.

Authors:  Jogender Mehla; Balwantsinh C Chauhan; Neelima B Chauhan
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

4.  Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview.

Authors:  Shikha Prasad; Ravi K Sajja; Pooja Naik; Luca Cucullo
Journal:  J Pharmacovigil       Date:  2014-06

Review 5.  Insulin resistance in the nervous system.

Authors:  Bhumsoo Kim; Eva L Feldman
Journal:  Trends Endocrinol Metab       Date:  2012-01-13       Impact factor: 12.015

Review 6.  Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art.

Authors:  Suzanne M de la Monte
Journal:  Expert Opin Drug Deliv       Date:  2013-11-12       Impact factor: 6.648

7.  Cardiovascular dementia - a different perspective.

Authors:  Udhaya Kumari; Klaus Heese
Journal:  Open Biochem J       Date:  2010-03-26

8.  Symptomatic cerebral oedema during treatment of diabetic ketoacidosis: effect of adjuvant octreotide infusion.

Authors:  Ora Seewi; Anne Vierzig; Bernhard Roth; Eckhard Schönau
Journal:  Diabetol Metab Syndr       Date:  2010-08-19       Impact factor: 3.320

Review 9.  Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.

Authors:  Jianing Meng; Vivek Agrahari; Ibrahima Youm
Journal:  J Neuroimmune Pharmacol       Date:  2016-07-23       Impact factor: 4.147

Review 10.  Novel treatment strategies for brain tumors and metastases.

Authors:  Salma E El-Habashy; Alaa M Nazief; Chris E Adkins; Ming Ming Wen; Amal H El-Kamel; Ahmed M Hamdan; Amira S Hanafy; Tori O Terrell; Afroz S Mohammad; Paul R Lockman; Mohamed Ismail Nounou
Journal:  Pharm Pat Anal       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.